NewsRx

Search our medical news database

Clinical Trial Research

Spherix Signs Definitive Agreement for Sale of Information Subsidiary

Published in Drug Law Weekly, July 10th, 2007

Spherix Incorporated (NASDAQ:SPEX) has signed the definitive agreement to sell the stock of its subsidiary, InfoSpherix Incorporated, to The Active Network Inc. Spherix will receive $17 million in an all cash transaction ($15 million at closing and $2 million following a 15-month escrow period). This combined with the $6 million received from the NRRS settlement (see Spherix press release dated October 26, 2006), will provide the necessary funding for Spherix's transition to a biotech company.

This matter will be put before Spherix's shareholders for vote at the 2007 Annual Shareholders Meeting. The Annual Meeting is tentatively scheduled to be held mid- to late-August,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook